Prosecution Insights
Last updated: April 19, 2026

Cugene Inc.

3 pending office actions

Portfolio Summary

3
Total Pending OAs
2
Final Rejections
1
Non-Final OAs

Pending Office Actions

App #TitleExaminerArt UnitStatusFiled
17784305 CYTOKINE-BASED BIOACTIVATABLE DRUGS AND METHODS OF USES THEREOF GURLEY, JAMI MICHELLE 1647 Final Rejection Jun 10, 2022
17784186 NOVEL INTERLEUKIN-15 (IL-15) FUSION PROTEINS AND USES THEREOF CARTER, SANDRA DILLAHUNT 1674 Non-Final OA Jun 10, 2022
17618207 NOVEL INTERLEUKIN-2 VARIANTS AND BIFUNCTIONAL FUSION MOLECULES THEREOF PATTERSON, SARAH COOPER 1675 Final Rejection Dec 10, 2021

Managing Cugene Inc.'s Patent Portfolio?

IP Author helps IP teams respond to office actions faster with AI-generated responses, examiner analytics, and prosecution intelligence.

Start Free Trial

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month